One such study that assessed the effectiveness of liver cancer screening in participants with chronic HBV (n = 5,581) in China, found that a higher proportion of those undertaking 6-monthly surveillance with AFP and ultrasound were diagnosed with early-stage liver cancer (29.6%) compared with those undergoing no surveillance (6.0%)40. This evidence concerns the gene AFP and liver cancer.